Medis
Nadja Ott, PharmD, is an experienced professional in the pharmaceutical and marketing sectors, currently serving as Global Product Manager for the CH Immune market at Medis since May 2004. In this role, Nadja oversees the sales and marketing strategies for products aimed at enhancing immune health, with a strong emphasis on market planning and competition analysis. Previous positions include Regional Brand Manager for various therapeutic areas, where responsibilities encompassed marketing for probiotic products, supplements for pregnant women, and medications for hepatic encephalopathy and cold/cough treatments across SCEE countries. Earlier experience includes a role at Merck as Regional Brand Manager in both OTC and Rx segments and as a Sales Representative for prescription drugs. Nadja holds a degree from the University of Ljubljana, Faculty of Pharmacy, completed in 2001.
This person is not in any offices
Medis
1 followers
For 34 years, we have been collaborating with global pharma and biotech partners to bring innovative therapies to patients in Central and Eastern Europe. Despite the region's challenging healthcare systems and complex yet promising markets, our team of 400 employees harnesses its expertise to ensure health equity in these underserved markets. Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for orphan and debilitating disease products. WODA covers 152 countries in the following regions: Central and Eastern Europe, Greater China, Israel, Greece, Malta, Cyprus, Latin America, the Middle East, North Africa & Turkey, Switzerland, Australia, New Zealand and South East Asia. Out-licensing: Become our commercialization partner and benefit from advanced, ready-to-launch consumer health products, which are already marketed in 20 countries and are further expanding. More information: www.medis.com/en/international-business/ Our business areas: • Therapeutics • Hospital Care • Consumer Health • Aesthetics Our value to partners: • Direct local presence in 18 CEE countries • Full commercialization • Single point of contact and delivery • Strategic and localized market access approach • Highest compliance standards • Financial and credit excellence Major Partners: • Therapeutics: Bial – Biogen – Besins – HRA Pharma – Mundipharma – Pierre Fabre – Santen – UCB • Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Paion • Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO • Aesthetics: Merz Aesthetics – Crown Aesthetics • Out-licensing partners: Ferrer – Pharmalink – Sarantis – Stada